Bayview Pharmacy is pleased to provide the compounded formulation of Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension, a specialized medication designed to effectively treat various ear conditions. This unique formulation is a combination of ciprofloxacin, a broad-spectrum antibiotic, and hydrocortisone, a corticosteroid. Together, these active ingredients work synergistically to combat bacterial infections and reduce inflammation, making it an effective treatment for conditions such as acute otitis externa, acute otitis media, and chronic otitis media.

The Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension is a liquid formulation specifically designed for use in the ear canal. It is administered using a specific ear dropper or applicator as directed, allowing for targeted treatment and easy absorption. The suspension form of this medication ensures a convenient application process, making it user-friendly for both adults and children over the age of 12. Depending on the severity of the condition, it can be used up to four times a day for a period of up to 10 days.

At Bayview Pharmacy, we are committed to providing high-quality compounded medications to meet the diverse needs of our patients. If you have any questions or require further information about the Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension or any of our other compounded medications, please do not hesitate to contact us. Our team is always ready to assist you in finding the most suitable treatment options for your patients.

Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension is a compounded formulation specifically designed for otic use. It is primarily indicated for the treatment of otitis externa caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus. Additionally, it is also used for the treatment of acute otitis media caused by susceptible strains of Streptococcus pneumoniae and Haemophilus influenzae.

This formulation is not intended for the treatment of viral or fungal infections. It is crucial for patients to complete the full course of treatment, even if symptoms appear to improve before completion. This is to ensure the complete eradication of the bacterial infection and to prevent the development of antibiotic-resistant strains.

Patients are advised to avoid contact with water while using this medication. In case of accidental contact, the medication should be immediately rinsed off. If symptoms do not improve or if they worsen, patients should promptly contact their healthcare provider.

It is also important for patients to inform their healthcare provider of any other medications they are currently taking. This is to avoid potential drug interactions that may affect the efficacy of the treatment or cause adverse effects. Always consult with your healthcare provider for any questions or concerns regarding your treatment.

Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension is a compounded formulation specifically designed to treat bacterial ear infections and inflammation of the ear canal. This dual-action medication works by eliminating the bacteria causing the infection and simultaneously reducing inflammation. It is an otic suspension, a liquid formulation that is directly applied into the ear canal for targeted treatment.

This medication is typically administered twice a day, once in the morning and once in the evening, over a course of 7-10 days. It is crucial to adhere to the instructions provided by your healthcare provider when using this medication to ensure its effectiveness.

Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension is effective against various bacterial ear infections, including otitis externa, otitis media, and acute otitis media. It is also used to alleviate inflammation of the ear canal caused by allergies, eczema, or other irritants. However, it is not designed to treat viral or fungal infections of the ear.

To administer Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension, tilt your head to the side and gently pull the earlobe up and back to straighten the ear canal. Position the tip of the bottle into the ear canal and gently squeeze to release the medication. After application, keep your head tilted for a few minutes to allow the medication to reach the affected area. Avoid rinsing the ear or wiping away the medication immediately after application.

It is essential to complete the entire course of treatment, even if symptoms improve before the medication is finished. Discontinuing the medication prematurely may result in the infection not being fully eradicated and potentially returning. If you have any questions or concerns about using Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension, it is recommended to consult with your healthcare provider.

Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension is a specialized liquid formulation designed for targeted treatment of various ear conditions. It is specifically intended for use in the ear canal and is administered using a specific ear dropper or applicator as directed by a healthcare provider. This formulation is indicated for the treatment of external otitis caused by organisms susceptible to its active ingredients, including Pseudomonas aeruginosa, Staphylococcus aureus, and Proteus mirabilis.

Additionally, Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension can be used to treat acute and chronic otitis media, as well as swimmer's ear. However, it is important to note that this formulation is not effective against malignant otitis externa and should not be used for this condition. Patients are advised to follow the usage instructions provided by their healthcare provider and to report any adverse effects immediately.

While this formulation is designed for targeted treatment, it is crucial that it is used correctly to ensure its effectiveness. Therefore, patients should always consult with their healthcare provider before starting any new medication regimen. If there are any questions or concerns about the use of Ciprofloxacin 0.3%/Hydrocortisone 1% Otic Suspension, patients should not hesitate to reach out to their healthcare provider for further information and guidance.